Georgia's Online Cancer Information Center

Find A Clinical Trial

Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors

Status
Completed
Cancer Type
Sarcoma
Trial Phase
Eligibility
18 - 50 Years, Male
Study Type
Other
NCT ID
NCT03206450
Protocol IDs
ALTE16C1 (primary)
ALTE16C1
COG-ALTE16C1
NCI-2017-01152
Study Sponsor
Children's Oncology Group

Summary

This research trial studies saliva, semen, and blood samples to determine effects of chemotherapy on fertility in osteosarcoma survivors. Study biospecimen samples from osteosarcoma survivors in the laboratory may help doctors learn whether chemotherapy causes fertility problems and to learn more about the long term effects.

Objectives

PRIMARY OBJECTIVES:
I. Determine whether infertility and/or biomarkers of spermatogenesis and steroidogenesis differ in male osteosarcoma survivors treated with cisplatin with or without ifosfamide compared to male controls without a history of cancer.
II. Evaluate whether cisplatin with or without ifosfamide for the treatment of osteosarcoma alters sperm deoxyribonucleic acid (DNA) methylation.

EXPLORATORY OBJECTIVES:
I. Evaluate the role of genetic susceptibility in the development of impairments in spermatogenesis or steroidogenesis with contemporary regimens for the treatment of osteosarcoma.

OUTLINE:
Participants complete a health questionnaire over 30-45 minutes. Patients also provide saliva and semen samples and undergo collection of blood.

Eligibility

  1. Received upfront therapies for osteosarcoma, which included cisplatin, (with or without other agents)
  2. Patient must have completed cancer treatment >= 2 years prior to study enrollment
  3. Osteosarcoma survivors without a systemically treated relapse or subsequent malignancy * Note: History of relapse or second malignancy is permitted if treated with local therapy only (e.g. surgery, radiation)
  4. Able to speak, read and write in English, French or Spanish
  5. All patients and/or their parents or legal guardians must sign a written informed consent
  6. All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

Treatment Sites in Georgia

Aflac Cancer and Blood Disorders Center of Children’s at Egleston


1405 Clifton Road NE
3rd Floor
Atlanta, GA 30322
404-785-0853
www.choa.org

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.